Fundz

CalciMedica Names Sean Lawler Chief Accounting Officer

PUBLIC · CALCNov 20, 2026
From SEC Form 3

Position

Chief Accounting Officer

Company

CalciMedica

Sean Lawler
La JollaBiotechnologyHealthcare

Description

Sean Lawler became Chief Accounting Officer of CalciMedica on November 10, 2026, per the SEC Form 3 filed November 19, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.

Quick answer

CalciMedica Names Sean Lawler Chief Accounting Officer (November 20, 2026). CalciMedica is based in La Jolla, California, United States.

Who is the new Chief Accounting Officer at CalciMedica?
CalciMedica named Sean Lawler Chief Accounting Officer, announced November 20, 2026.
What did CalciMedica announce on November 20, 2026?
Sean Lawler became Chief Accounting Officer of CalciMedica on November 10, 2026, per the SEC Form 3 filed November 19, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
What does CalciMedica do?
CalciMedica is a privately held, clinical stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases.
Where is CalciMedica based?
CalciMedica is based in La Jolla, California, United States.
Which similar companies made leadership changes around the same time?
Milestone Pharmaceuticals (November 20, 2026), Corvex Legacy Holdings (November 19, 2026), CytoDyn (November 18, 2026) and Procyrion (November 17, 2026) also announced leadership changes within 45 days of CalciMedica.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at CalciMedica, and when

A new leader at CalciMedica brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day CalciMedica raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CalciMedica, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CalciMedica. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CalciMedica

Location

505 COAST BOULEVARD SOUTH

La Jolla, California, United States

About

CalciMedica is a privately held, clinical stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases. The Company was founded in 2007 by Ken Stauderman, CalciMedica’s Chief Scientific Officer, and colleagues at Torrey Pines Therapeutics in San Diego and Harvard’s Center for Blood Research in Cambridge, MA. Dr. Stauderman’s work includes the discovery of the role of STIM1, which works in concert with Orai1 in the CRAC channels targeted by CalciMedica’s drugs. The Company has a portfolio of highly selective CRAC channel inhibitor drugs that it is developing to improve outcomes for patients with acute inflammatory indications. It has also assembled a portfolio of patents and patent applications covering those compounds as well as different aspects of CRAC channel biology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CalciMedica changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sudarshan
Likely contact at this company
••••••••@••••••••

See Sudarshan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CalciMedica's next move

Learn about Strategic plan

CalciMedica changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.